Polymedica Corp (MM) (NASDAQ:PLMD)
Historical Stock Chart
From Jan 2020 to Jan 2025
PolyMedica Corporation (NASDAQ: PLMD) today announced several senior
management promotions.
Stephen C. Farrell, age 41, has been promoted from Chief Operating
Officer of PolyMedica Corporation to President. Steve has previously
held the positions of Chief Financial Officer of PolyMedica and
President of Liberty Healthcare Group. Prior to joining PolyMedica in
1999 as Treasurer, Steve was a Senior Manager of the High Technology
Team of PricewaterhouseCoopers, where he worked for five years. Steve
has served on the Bay State Board of Juvenile Diabetes Research
Foundation since 2003. He is a graduate of Harvard College, holds an
M.B.A. from the University of Virginia and is a Certified Public
Accountant.
Keith W. Jones, age 40, has been promoted from Chief Financial Officer
to Chief Operating Officer. Before joining PolyMedica in February 2005,
Keith was a co-founder and served as Chief Financial Officer and Vice
President of Physicians Dialysis, Inc., until its sale to DaVita Inc. in
2004. Positions held prior to Physicians Dialysis include serving as
Chief Financial Officer for Craftopia.com, Inc. as well as Chief
Accounting Officer/Corporate Controller for Renal Treatment Centers,
Inc. He began his career as a Senior Accountant at Coopers & Lybrand. He
is a Certified Public Accountant and holds a B.A. degree from Franklin
and Marshall College.
Jonathan A. Starr, age 36, has been promoted to Chief Financial Officer
of PolyMedica Corporation from Senior Vice President and Chief Financial
Officer of PolyMedica’s Liberty Healthcare
Group subsidiary. Jonathan has been with PolyMedica since 1993 in
various financial roles, including Director of Finance of PolyMedica and
Vice President of Finance for Liberty Home Pharmacy, a former PolyMedica
subsidiary. Mr. Starr holds a B.A. degree from Clark University and an
M.B.A. from The Bentley Graduate School of Business.
Commenting on the promotions, Chief Executive Officer Patrick Ryan said, “We
are extremely fortunate to have within our company such a talented group
of individuals who have proven themselves capable of increased
responsibility. We are pleased that we can reward their hard work and
dedication through promotion. Steve has been an invaluable part of
PolyMedica’s success to date, and, in his new
role, he will continue to focus on growing the Company and helping to
fulfill the potential of PolyMedica. Keith’s
financial background and his hands-on knowledge of the financial and
operating workings of the Company will be extremely helpful as he
focuses on operations. Jonathan has held numerous financial positions
within PolyMedica for more than 13 years and has been integral in the
Company’s growth and financial discipline.
Together, this team will lead an internal initiative to enhance the
operating efficiency and growth of PolyMedica by creating tighter
integration between our business units, expanding our clinical and
diabetes service portfolio and focusing the entire organization on
providing the best possible care for our patients.”
About PolyMedica
For more than a decade, PolyMedica Corporation has been the nation’s
largest provider of blood glucose testing supplies and related services
to people with diabetes and today serves more than 925,000 active
patients. The Company is expanding its portfolio of products and
services, from patient education to prescription drugs, to help people
better manage their conditions and maintain their health. Through
proactive patient outreach, convenient home delivery and administrative
support, PolyMedica makes it simple for patients to obtain the supplies
and medications they need, while encouraging compliance with physicians’
orders. More information about PolyMedica can be found on the Company’s
website at www.polymedica.com.
This press release contains forward-looking statements as that term
is defined in the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are subject to risks and uncertainties, which
could cause actual results to differ materially from those anticipated.
Such risks and uncertainties include, but are not limited to, rules
and regulations promulgated under the Act, unanticipated changes in
Medicare reimbursement, successful participation in new reimbursement
programs, outcomes of government reviews, inquiries, investigations and
related litigation, continued compliance with government regulations,
fluctuations in customer demand, management of rapid growth, competition
from other healthcare product vendors, timing and acceptance of new
product introductions, general economic conditions, geopolitical events
and regulatory changes, as well as other especially relevant risks
detailed in the Company’s filings with the
Securities and Exchange Commission, including its Annual Report on Form
10-K for the period ended March 31, 2006, and Quarterly Reports on Form
10-Q for the periods ended June 30, 2006, September 30, 2006 and
December 31, 2006. The information set forth herein should be
read in light of such risks. The Company assumes no obligation to
update the information contained in this press release.